Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in Russia

Elena Kuzmina, Ekaterina Chelysheva, Elza Lomaia, Elena V Morozova, Oleg Shukhov, Anna Petrova, Tamara Chitanava, Julia Vlasova, Evgenia Sbitiakova, Natalia Lazorko, Irina Nemchenko, Anastasiya Vitalievna Bykova, Margarita Gurianova, Alina Kokhno, Anna Turkina

Blood (2023) 142 (Supplement 1): 1803.

https://doi.org/10.1182/blood-2023-181789

Published: 2023

Journal Articles

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Anna Turkina, Elena A. Kuzmina, Elza Lomaia, Elena Morozova, Oleg A. Shukhov, Anna N. Petrova, Tamara Chitanava, Julia J. Vlasova, Ekaterina Yu. Chelysheva, Evgeniya Sbityakova, Irina S. Nemchenko, Anastasiya V. Bykova, Margarita A. Gurianova, Alina V. Kokhno, Elena N. Parovichnikova

Blood (2022) 140 (Supplement 1): 9654–9655.

https://doi.org/10.1182/blood-2022-162268

Published: 2022

Journal Articles

Comparative Characteristics of the Effectiveness of Tyrosine Kinase Inhibitors Vs Allogeneic Hematopoietic Stem Cell Transplantation in the Chronic Phase of Chronic Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 12192–12193.

https://doi.org/10.1182/blood-2022-163506

Published: 2022

Journal Articles

The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian Federation

Anna G. Turkina, Oleg A. Shukhov, Elza Lomaia, Elena V. Morozova, Anna Petrova, Ekaterina Yu. Chelysheva, Tamara Chitanava, Julia J. Vlasova, Irina Nemchenko, Anastasiya Bykova, Margarita Gurianova, Andrey Zaritsky

Blood (2021) 138 (Supplement 1): 1483.

https://doi.org/10.1182/blood-2021-145712

Published: 2021